# Karyopharm Therapeutics Inc.: Form 8-K, filed Nov 3, 2025

- Company: [Karyopharm Therapeutics Inc.](/companies/kpti.md) (CIK 1503802)
- Form: 8-K
- Filed: 2025-11-03
- Accepted by EDGAR: Nov 3, 2025, 07:10 ET
- Period: 2025-11-03
- Accession: 0001193125-25-261663
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1503802/000119312525261663/kpti-20251103.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1503802/000119312525261663/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1503802/000119312525261663/kpti-20251103.htm

Filed Nov 3, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-261663. Last ingested by Listed: Oct 29, 2026, 04:32 ET. No prices; not investment advice.